Top Markets
Coin of the day
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Classificação em ações #16450
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Preço da ação
$4.64
Última sincronização: 2022-09-12
Valor de mercado
$293.43M
Variação (1 dia)
0.87%
Variação (1 ano)
0.00%
País
US
Negociar Adagio Therapeutics, Inc. (ADGI)

Categoria

Preço ADGI com a capitalização de mercado de B
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
ADGI
$4.64
Capitalização de mercado de Adagio Therapeutics, Inc.(ADGI)
Valor de mercado: $293.43M
Em September 2026, Adagio Therapeutics, Inc. tem uma capitalização de mercado de $293.43M. Isso faz com que Adagio Therapeutics, Inc. seja a 16450th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Adagio Therapeutics, Inc. de 2021 a 2026
ADGI comparado com o topo de 5 mais populares stocks
Preço para ADGI Ativo B Capitalização de mercado de B Resultados
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
$83,169.03 $293.43M
$5.260T +1,792,336.04%
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
$75,561.85 $293.43M
$4.779T +1,628,388.14%
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
$63,515.83 $293.43M
$4.017T +1,368,775.61%
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
$58,812.61 $293.43M
$3.719T +1,267,413.16%
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
$43,235.92 $293.43M
$2.734T +931,708.65%